Scroll
To Top

Archives for: July 23rd, 2015

NORD Issues Statement on FDA’s New Associate Director for Rare Diseases

Written by Jennifer Huron on July 23, 2015

The following statement was issued by Peter L. Saltonstall, President and CEO of the National Organization for Rare Disorders (NORD), on today’s announcement that Jonathan C. Goldsmith, MD, FACP, will lead the Rare Diseases Program in the Center for Drug Evaluation and Research (CDER) Office of New Drugs at the… Read More